Engineering Yarrowia lipolytica for the biosynthesis of geraniol

Geraniol is a monoterpene with wide applications in the food, cosmetics, and pharmaceutical industries. Microbial production has largely used model organisms lacking favorable properties for monoterpene production. In this work, we produced geraniol in metabolically engineered Yarrowia lipolytica. F...

Full description

Bibliographic Details
Main Authors: Ayushi Agrawal, Zhiliang Yang, Mark Blenner
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Metabolic Engineering Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214030123000111
_version_ 1797405467777957888
author Ayushi Agrawal
Zhiliang Yang
Mark Blenner
author_facet Ayushi Agrawal
Zhiliang Yang
Mark Blenner
author_sort Ayushi Agrawal
collection DOAJ
description Geraniol is a monoterpene with wide applications in the food, cosmetics, and pharmaceutical industries. Microbial production has largely used model organisms lacking favorable properties for monoterpene production. In this work, we produced geraniol in metabolically engineered Yarrowia lipolytica. First, two plant-derived geraniol synthases (GES) from Catharanthus roseus (Cr) and Valeriana officinalis (Vo) were tested based on previous reports of activity. Both wild type and truncated mutants of GES (without signal peptide targeting chloroplast) were examined by co-expressing with MVA pathway enzymes tHMG1 and IDI1. Truncated CrGES (tCrGES) produced the most geraniol and thus was used for further experimentation. The initial strain was obtained by overexpression of the truncated HMG1, IDI and tCrGES. The acetyl-CoA precursor pool was enhanced by overexpressing mevalonate pathway genes such as ERG10, HMGS or MVK, PMK. The final strain overexpressing 3 copies of tCrGES and single copies of ERG10, HMGS, tHMG1, IDI produced approximately 1 g/L in shake-flask fermentation. This is the first demonstration of geraniol production in Yarrowia lipolytica and the highest de novo titer reported to date in yeast.
first_indexed 2024-03-09T03:11:25Z
format Article
id doaj.art-d5cf8a74012440d8837404cae8faa856
institution Directory Open Access Journal
issn 2214-0301
language English
last_indexed 2024-03-09T03:11:25Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Metabolic Engineering Communications
spelling doaj.art-d5cf8a74012440d8837404cae8faa8562023-12-04T05:21:52ZengElsevierMetabolic Engineering Communications2214-03012023-12-0117e00228Engineering Yarrowia lipolytica for the biosynthesis of geraniolAyushi Agrawal0Zhiliang Yang1Mark Blenner2Department of Chemical and Biomolecular Engineering, 590 Avenue 1743, University of Delaware, Newark, DE, 19713, USADepartment of Chemical and Biomolecular Engineering, Clemson University, 206 S. Palmetto Blvd., Clemson, SC, 29634, USADepartment of Chemical and Biomolecular Engineering, 590 Avenue 1743, University of Delaware, Newark, DE, 19713, USA; Department of Chemical and Biomolecular Engineering, Clemson University, 206 S. Palmetto Blvd., Clemson, SC, 29634, USA; Corresponding author. Department of Chemical and Biomolecular Engineering, 590 Avenue 1743, University of Delaware, Newark, DE, 19713, USA.Geraniol is a monoterpene with wide applications in the food, cosmetics, and pharmaceutical industries. Microbial production has largely used model organisms lacking favorable properties for monoterpene production. In this work, we produced geraniol in metabolically engineered Yarrowia lipolytica. First, two plant-derived geraniol synthases (GES) from Catharanthus roseus (Cr) and Valeriana officinalis (Vo) were tested based on previous reports of activity. Both wild type and truncated mutants of GES (without signal peptide targeting chloroplast) were examined by co-expressing with MVA pathway enzymes tHMG1 and IDI1. Truncated CrGES (tCrGES) produced the most geraniol and thus was used for further experimentation. The initial strain was obtained by overexpression of the truncated HMG1, IDI and tCrGES. The acetyl-CoA precursor pool was enhanced by overexpressing mevalonate pathway genes such as ERG10, HMGS or MVK, PMK. The final strain overexpressing 3 copies of tCrGES and single copies of ERG10, HMGS, tHMG1, IDI produced approximately 1 g/L in shake-flask fermentation. This is the first demonstration of geraniol production in Yarrowia lipolytica and the highest de novo titer reported to date in yeast.http://www.sciencedirect.com/science/article/pii/S2214030123000111GeraniolYarrowia lipolyticaMonoterpeneMetabolic engineering
spellingShingle Ayushi Agrawal
Zhiliang Yang
Mark Blenner
Engineering Yarrowia lipolytica for the biosynthesis of geraniol
Metabolic Engineering Communications
Geraniol
Yarrowia lipolytica
Monoterpene
Metabolic engineering
title Engineering Yarrowia lipolytica for the biosynthesis of geraniol
title_full Engineering Yarrowia lipolytica for the biosynthesis of geraniol
title_fullStr Engineering Yarrowia lipolytica for the biosynthesis of geraniol
title_full_unstemmed Engineering Yarrowia lipolytica for the biosynthesis of geraniol
title_short Engineering Yarrowia lipolytica for the biosynthesis of geraniol
title_sort engineering yarrowia lipolytica for the biosynthesis of geraniol
topic Geraniol
Yarrowia lipolytica
Monoterpene
Metabolic engineering
url http://www.sciencedirect.com/science/article/pii/S2214030123000111
work_keys_str_mv AT ayushiagrawal engineeringyarrowialipolyticaforthebiosynthesisofgeraniol
AT zhiliangyang engineeringyarrowialipolyticaforthebiosynthesisofgeraniol
AT markblenner engineeringyarrowialipolyticaforthebiosynthesisofgeraniol